Anastomosis, Surgical
0
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
GT BiopharmaSAN FRANCISCO, CA
1 programSide-to-side duodenal-ileal anastomosisN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2025
2026
2027
MicrosureRobot-assisted microsurgical anastomoses
GT BiopharmaSide-to-side duodenal-ileal anastomosis
Clinical Trials (2)
Evaluation of MUSA-3 in Microsurgical Anastomoses
Start: Apr 2026Est. completion: Sep 2026
N/ANot Yet Recruiting
MagDI U.S. Registry
Start: Mar 2025Est. completion: Apr 2027
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials
2 companies competing in this space